acetate salt is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-18. Numbers and descriptions here follow the published literature rather than marketing material.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
| Property | Value | Notes |
|---|---|---|
| Molar mass | Approximately 1419.5 g/mol | Calculated from the reported 15-residue sequence |
| Molecular formula | C62H98N16O22 | Based on the same sequence |
| Appearance | White to off-white powder | Typical of a lyophilized preparation |
| Solubility class | Freely soluble in water | Also dissolves in saline solutions |
| Typical storage temperature | Minus 20 degrees Celsius, dry | Refrigeration advised after reconstitution |
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
== Ligand variations == Since the initial MPAA ligand report, many variations of bifunctional ligands derived from amino acids have been developed. Bidentate MPAQ (mono-protected amino quinoline) ligands were introduced in the application of β-methylene C–H bonds in aliphatic amides. The highly successful MPAO (mono-protected amino oxazoline) ligand allowed for C(sp3)–H functionalization via arylation of α-methyls, borylation of cyclobutyl carboxylic amides, and boronic cross coupling of alkyl amines. MPAAM (mono-protected aminoalkyl amine) ligands were used in enantioselective C(sp3)–H arylations of free aliphatic acids without the need for exogenous directing groups. Variations of the MPAAThio (mono-protected aminoalkyl thioether) ligands have been use in olefination of free carboxylic acids and arylation, carbonylation, and olefination of free aliphatic amines. Expanding the reaction substrate scope to non-directed C(sp2)–H bonds, pyridone ligands were developed to functionalize arenes and heteroarenes which proved to be particularly useful in late-state derivatization of bioactive compounds such as estrone, caffeine, and camptothecin. Many analogues of the pyridine-pyridone (azine-pyridone) ligands were developed and used in the C(sp2)–H hydroxylation of (hetero)arenes and the dehydrogenation of methylene C(sp3)–H bonds on alkyl free acids.
Clematis addisonii Britt. – Addison's leather flower Clematis akebioides (Maxim.) H.J.Veitch Clematis albicoma Wherry – whitehair leather flower Clematis alpina (L.) Mill. – alpine clematis Clematis aristata R.Br. ex Ker Gawl. – Australian clematis Clematis armandii – Armand clematis Clematis baldwinii Torr. & A.Gray – pine hyacinth Clematis bigelovii Torr. – Bigelow clematis Clematis brachiata Thunb. – traveller's joy Clematis campaniflora Brot. – Portuguese clematis Clematis catesbyana – satin curls Clematis chinensis Osbeck – wei ling xian in Chinese (Chinese: 威靈仙; pinyin: Wei ling xian) Clematis chrysocoma Franch. – gold wool clematis Clematis cirrhosa L. – includes the 'Freckles', 'Wisley Cream', and 'Jingle Bells' cultivars Clematis cirrhosa v. balearica (Balearic Islands) Clematis coactilis (Fern.) Keener – Virginia whitehair leather flower Clematis columbiana (Nutt.) Torr. & A.Gray – British Columbia virgin's bower Clematis crispa L. – swamp leather flower Clematis cunninghamii Clematis dioica L. – cabellos de angel Clematis drummondii Torr. & A.Gray – Drummond clematis Clematis durandii Clematis fawcettii F.Muell. Clematis flammula L. – fragrant virgin's bower Clematis florida Thunb. – Asian clematis Clematis foetida Raoul (1846) – New Zealand clematis Clematis fremontii S.Watson – Fremont's leather flower Clematis glaucophylla Small – whiteleaf leather flower Clematis glycinoides DC. – headache vine Clematis gouriana – Indian traveller's joy Clematis henryi Oliv. Clematis hirsutissima Pursh – hairy clematis Clematis hedysarifolia DC. Clematis integrifolia L.
Impact factor data ... have a strong influence on the scientific community, affecting decisions on where to publish, whom to promote or hire, the success of grant applications, and even salary bonuses. More targeted research has begun to provide firm evidence of how deeply the impact factor is embedded within formal and informal research assessment processes. A review in 2019 studied how often the JIF featured in documents related to the review, promotion, and tenure of scientists in US and Canadian universities. It concluded that 40% of universities focused on academic research specifically mentioned the JIF as part of such review, promotion, and tenure processes. A 2017 study of how researchers in the life sciences behave concluded that "everyday decision-making practices as highly governed by pressures to publish in high-impact journals." It has been argued that the deeply embedded nature of such indicators not only affects research assessment, but the more fundamental issue of what research is actually undertaken: "Given the current ways of evaluation and valuing research, risky, lengthy, and unorthodox project rarely take center stage."
Sources: en.wikipedia.org
== Common biological stains == Different stains react or concentrate in different parts of a cell or tissue, and these properties are used to advantage to reveal specific parts or areas. Some of the most common biological stains are listed below. Unless otherwise marked, all of these dyes may be used with fixed cells and tissues; vital dyes (suitable for use with living organisms) are noted.
=== Traditional accelerationism === Traditional accelerationism, as developed by the British philosopher Nick Land, sees the acceleration of technological change as a way to bring about a fundamental transformation of current culture, society, and the political economy. This is done through capitalism, which Land views as "an autonomous force that’s reconfiguring society" that can overcome its limits if intensified. Land's work has also been characterized as concerning "the supposedly inevitable 'disintegration of the human species' when artificial intelligence improves sufficiently." While both concern ideas like a technocapital singularity and AGI progress, effective accelerationism focuses on using AGI for the greatest ethical good for conscious life and civilization (whether human or machine), as well as expanding civilization and maximizing energy usage in order to align with the "will of the universe". Land focuses on capitalist self-optimization as the driver of modernity, progress, and the eroding of existing social orders. Land has expressed support for effective accelerationism, while Thomas Murphy referred to the movement as "Nick Land diluted for LinkedIn".
The original Pennsylvania Station was an ornate station building designed by McKim, Mead, and White and considered a masterpiece of the Beaux-Arts style. Completed in 1910, it enabled direct rail access to New York City from the south for the first time. Its head house and train shed were torn down in 1963 at a time of low train ridership, with the rail infrastructure reconstituted as the smaller underground station that survives today. The New York Times editorial board described the demolition of the original station as a "monumental act of vandalism", and its destruction galvanized the modern historic preservation movement. As rail travel increased again in the following decades, the underground station began to operate beyond its design capacity. By 2015, the station handled 650,000 travelers daily (more than the region's three major airports combined) and had become loathed for its cramped, claustrophobic conditions. The 2020s saw the opening of Moynihan Train Hall, a head house that expanded Penn Station into the Farley building, as well as expansion of the LIRR concourse and a new direct entrance from 33rd Street. Plans under development call for reconstruction of the core of the station, with competing proposals regarding the station's relationship to Madison Square Garden under consideration. Looking back on the pace of reconstruction since the announcement of Moynihan Hall in 1999, the Times noted in 2025 that "More than 25 years, five presidencies and four governors later, the plan to rebuild Penn Station is nowhere near completion."
== Structure and function == The viral envelope of an enveloped virus has different surface proteins from the rest of the virus which act as antigens. These antigens are recognized by antibody proteins that bind specifically to one of these surface proteins. The full-length HBsAg is called the L (for "large") form. It consists of a preS loop, a first transmembrane helix (TM1), a cytosolic loop (CYL), another TM helix (TM2), an antigenic loop (AGL), followed by two TM helices (TM3 and TM4). The preS loop can either be on the outside (lumen), or be located in the cytosol with the TM1 helix not actually penetrating the membrane. The M ("medium") form has a truncated preS; the part of preS1 unique to L is called preS1, while the part shared by L and M is called preS2. preS2 is always located in the lumen. The S ("small") form has no preS2. HBsAg forms the shell of the virus. Furthermore, it contains parts that are recognized by the cellular receptor of the virus NTCP in preS1, which causes the virus to tightly bind to the cell. How the virus convinces the cell to take the virus in after binding via endocytosis is unknown. It also serves to release the contents of the virion into the cell through membrane fusion. The part responsible for fusion is also located in preS1. HBsAg self-assembles into viral shells even when no contents are present. Such an empty shell is called a virus-like particle or a small spherical subviral particle.
Sources: en.wikipedia.org
CAS registry number – Chemical identifierPages displaying short descriptions of redirect targets Chemical nomenclature – Systematic naming of chemical compounds Commission on Isotopic Abundances and Atomic Weights – International scientific committee European Association for Chemical and Molecular Sciences Institute for Reference Materials and Measurements (IRMM) – Promotes a common European measurement system International Chemical Identifier (InChI) – Identifier for chemical substances International Union of Biochemistry and Molecular Biology (IUBMB) – International non-governmental organization International Union of Pure and Applied Physics (IUPAP) – Non-governmental organization for physics development List of chemical elements naming controversies National Institute of Standards and Technology (NIST) – Measurement standards laboratory in the United States Simplified molecular-input line-entry system (SMILES) – Chemical species structure notationPages displaying short descriptions of redirect targets
a mother teaching her children their father's tongue has been a recurrent, ubiquitous and prevalent pattern throughout linguistic history, […] some of the mechanisms of language change over time are likely to be inherent to the dynamics of this pathway of transmission. Such correlations are observed worldwide.
For its 1994 reunion, King Crimson reassessed both the mid-1970s and 1980s approaches in the light of new technology, intervening music forms such as drum and bass and techno, and further developments in industrial music, as well as expanding the band's ambient textural content via Fripp's Soundscapes. The 2013 version of the band returned, for the most part, to the band's 1960s and 1970s influences and repertoire but addressed them via current technology and rearrangements suited to a larger ensemble of more experienced musicians, while also incorporating the new standard tuning used by Fripp since 1984.
Sources: en.wikipedia.org
It does not occur in the form that is supplied commercially. Its sequence matches a fragment of a larger gastric protein, and the research material is produced synthetically in a laboratory. The fragment described in the early literature is generally the same synthetic pentadecapeptide.
It marks the position of the sequence inside the original protein. The label traces back to early work fractionating gastric juice and describing a body protection compound. The figure does not refer to molecular weight or to the count of amino acids.
No. The sequence has no cysteine residues, so disulfide bridges cannot form. That feature makes it easier to handle than many small proteins that depend on multiple cysteines for structure.
It is a synthetic peptide built from fifteen amino acids, with a mass of roughly 1419 daltons. The sequence is reported to match a fragment of a protein present in human gastric juice. It is not a naturally circulating hormone.